Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

Shahina Daar*, Anil Pathare, Hanspeter Nick, Ulrike Kriemler-Krahn, Abdel Hmissi, Dany Habr, Ali Taher

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

64 اقتباسات (Scopus)

بصمة

أدرس بدقة موضوعات البحث “Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia'. فهما يشكلان معًا بصمة فريدة.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Medicine and Dentistry

Agricultural and Biological Sciences